• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏安全研究联合会心电图数据库:透彻 QT 数据库规格和使用原则,用于算法开发和测试。

The Cardiac Safety Research Consortium electrocardiogram warehouse: thorough QT database specifications and principles of use for algorithm development and testing.

机构信息

Division of Cardiology, Department of Medicine, Weill Cornell Medical College, New York, NY 10065, USA.

出版信息

Am Heart J. 2010 Dec;160(6):1023-8. doi: 10.1016/j.ahj.2010.09.002.

DOI:10.1016/j.ahj.2010.09.002
PMID:21146653
Abstract

This document examines the formation, structure, and principles guiding the use of electrocardiogram (ECG) data sets obtained during thorough QT studies that have been derived from the ECG Warehouse of the Cardiac Safety Research Consortium (CSRC). These principles are designed to preserve the fairness and public interest of access to these data, commensurate with the mission of the CSRC. The data sets comprise anonymized XML formatted digitized ECGs and descriptive variables from placebo and positive control arms of individual studies previously submitted on a proprietary basis to the US Food and Drug Administration by pharmaceutical sponsors. Sponsors permit the release of these studies into the public domain through the CSRC on behalf of the Food and Drug Administration's Critical Path Initiative and public health interest. For algorithm research protocols submitted to and approved by CSRC, unblinded "training" ECG data sets are provided for algorithm development and for initial evaluation, whereas separate blinded "testing" data sets are used for formal algorithm evaluation in cooperation with the CSRC according to methods detailed in this document.

摘要

本文件探讨了在全面 QT 研究中获得的心电图 (ECG) 数据集的形成、结构和指导使用原则,这些数据集源自心脏安全研究联盟 (CSRC) 的心电图仓库。这些原则旨在保护公平公正地获取这些数据的机会,同时符合 CSRC 的使命。数据集包括匿名的 XML 格式数字化 ECG 和描述性变量,来自先前以专有方式向美国食品和药物管理局提交的单个研究的安慰剂和阳性对照臂。赞助商允许通过 CSRC 将这些研究发布到公共领域,代表食品和药物管理局的关键路径倡议和公共卫生利益。对于提交给 CSRC 并获得批准的算法研究方案,提供了未屏蔽的“训练”ECG 数据集,用于算法开发和初步评估,而单独的屏蔽“测试”数据集则根据本文详细方法与 CSRC 合作用于正式的算法评估。

相似文献

1
The Cardiac Safety Research Consortium electrocardiogram warehouse: thorough QT database specifications and principles of use for algorithm development and testing.心脏安全研究联合会心电图数据库:透彻 QT 数据库规格和使用原则,用于算法开发和测试。
Am Heart J. 2010 Dec;160(6):1023-8. doi: 10.1016/j.ahj.2010.09.002.
2
The Cardiac Safety Research Consortium ECG database.心脏安全研究联盟心电图数据库。
J Electrocardiol. 2012 Nov-Dec;45(6):690-2. doi: 10.1016/j.jelectrocard.2012.07.012. Epub 2012 Sep 19.
3
Detection of QT prolongation using a novel electrocardiographic analysis algorithm applying intelligent automation: prospective blinded evaluation using the Cardiac Safety Research Consortium electrocardiographic database.应用智能自动化的新型心电图分析算法检测 QT 间期延长:使用心脏安全研究联合会心电图数据库进行前瞻性盲法评估。
Am Heart J. 2012 Mar;163(3):365-71. doi: 10.1016/j.ahj.2011.11.009. Epub 2012 Feb 27.
4
Quantitative performance of E-Scribe warehouse in detecting quality issues with digital annotated ECG data from healthy subjects.E-Scribe仓库在检测来自健康受试者的数字注释心电图数据质量问题方面的定量性能。
J Clin Pharmacol. 2008 May;48(5):538-46. doi: 10.1177/0091270008316326. Epub 2008 Mar 19.
5
Research implications of the FDA ECG warehouse and related resources.FDA 心电图仓库及相关资源的研究意义。
J Electrocardiol. 2019 Nov-Dec;57S:S27-S33. doi: 10.1016/j.jelectrocard.2019.09.009. Epub 2019 Sep 7.
6
Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.样本量、效能计算及其对药物诱导的QT间期延长深入研究成本的影响。
Pacing Clin Electrophysiol. 2004 Dec;27(12):1659-69. doi: 10.1111/j.1540-8159.2004.00701.x.
7
An algorithm for QT interval monitoring in neonatal intensive care units.一种用于新生儿重症监护病房QT间期监测的算法。
J Electrocardiol. 2007 Nov-Dec;40(6 Suppl):S103-10. doi: 10.1016/j.jelectrocard.2007.06.019.
8
Quality assessment of digital annotated ECG data from clinical trials by the FDA ECG Warehouse.美国食品药品监督管理局心电图数据库对来自临床试验的数字注释心电图数据的质量评估。
Expert Opin Drug Saf. 2007 Sep;6(5):595-607. doi: 10.1517/14740338.6.5.595.
9
Precision of QT interval measurement by advanced electrocardiographic equipment.先进心电图设备测量QT间期的精度。
Pacing Clin Electrophysiol. 2006 Nov;29(11):1277-84. doi: 10.1111/j.1540-8159.2006.00532.x.
10
Man versus machine: is there an optimal method for QT measurements in thorough QT studies?人机对比:在全面的QT研究中,是否存在QT测量的最佳方法?
J Clin Pharmacol. 2006 Jun;46(6):598-612. doi: 10.1177/0091270006286900.

引用本文的文献

1
A Computational Pipeline to Predict Cardiotoxicity: From the Atom to the Rhythm.一种预测心脏毒性的计算流程:从原子到节律。
Circ Res. 2020 Apr 10;126(8):947-964. doi: 10.1161/CIRCRESAHA.119.316404. Epub 2020 Feb 24.
2
Towards Bridging Translational Gap in Cardiotoxicity Prediction: an Application of Progressive Cardiac Risk Assessment Strategy in TdP Risk Assessment of Moxifloxacin.迈向心脏毒性预测的转化鸿沟弥合:在莫西沙星 TdP 风险评估中应用渐进式心脏风险评估策略。
AAPS J. 2018 Mar 14;20(3):47. doi: 10.1208/s12248-018-0199-4.
3
The Role of Public-Private Partnerships in Catalyzing the Critical Path.
公私伙伴关系在推动关键路径方面的作用。
Clin Transl Sci. 2017 Nov;10(6):431-442. doi: 10.1111/cts.12488. Epub 2017 Aug 3.
4
ECG-ViEW II, a freely accessible electrocardiogram database.心电图视图II,一个可免费访问的心电图数据库。
PLoS One. 2017 Apr 24;12(4):e0176222. doi: 10.1371/journal.pone.0176222. eCollection 2017.
5
Automated Algorithm for J-Tpeak and Tpeak-Tend Assessment of Drug-Induced Proarrhythmia Risk.用于评估药物诱导的心律失常风险的J峰和T峰-终末间期的自动算法
PLoS One. 2016 Dec 30;11(12):e0166925. doi: 10.1371/journal.pone.0166925. eCollection 2016.
6
Universal Correction for QT/RR Hysteresis.QT/RR滞后的通用校正
Drug Saf. 2016 Jun;39(6):577-88. doi: 10.1007/s40264-016-0406-0.
7
Detecting moxifloxacin-induced QTc prolongation in thorough QT and early clinical phase studies using a highly automated ECG analysis approach.在全面QT和早期临床阶段研究中,使用高度自动化的心电图分析方法检测莫西沙星引起的QTc延长。
Br J Pharmacol. 2016 Apr;173(8):1373-80. doi: 10.1111/bph.13436. Epub 2016 Mar 4.
8
The IQ-CSRC prospective clinical Phase 1 study: "Can early QT assessment using exposure response analysis replace the thorough QT study?".IQ-CSRC前瞻性临床1期研究:“使用暴露-反应分析进行早期QT评估能否取代全面的QT研究?”
Ann Noninvasive Electrocardiol. 2014 Jan;19(1):70-81. doi: 10.1111/anec.12128. Epub 2013 Dec 30.
9
Dealing with global safety issues : was the response to QT-liability of non-cardiac drugs well coordinated?应对全球安全问题:非心脏药物致 QT 间期延长风险的应对是否协调一致?
Drug Saf. 2013 Mar;36(3):167-82. doi: 10.1007/s40264-013-0016-z.
10
Early investigation of QTc liability: the role of multiple ascending dose (MAD) study.早期 QTc 责任调查:多剂量递增(MAD)研究的作用。
Drug Saf. 2012 Sep 1;35(9):695-709. doi: 10.1007/BF03261967.